Polypharmacy or Mobility Assessment in Patients With Haematological Malignancies: Polypharmacy Is Highly Prevalent and Prognostic, Impaired Mobility Is Prognostic, Medications May Impact Mobility
Comments 0
Login to view comments.
Click here to Login
